LC-MB12

CAS No. 2828438-38-4

LC-MB12( —— )

Catalog No. M37588 CAS No. 2828438-38-4

LC-MB12 is an orally active, selective and potent PROTAC FGFR2 complex that degrades FGFR2.LC-MB12 has antiproliferative and antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 516 In Stock
5MG 325 In Stock
10MG 522 In Stock
25MG 1026 In Stock
50MG 1637 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LC-MB12
  • Note
    Research use only, not for human use.
  • Brief Description
    LC-MB12 is an orally active, selective and potent PROTAC FGFR2 complex that degrades FGFR2.LC-MB12 has antiproliferative and antitumor activity.
  • Description
    LC-MB12 is an orally active PROTAC compound targets FGFR2degradation with a DC50 of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity.
  • In Vitro
    Cell Viability Assay Cell Line:KATO III, SNU-16, NCI-H716 Concentration:0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM Incubation Time:72 h Result:Inhibited cell growth with IC50s value of 29.1 nM (KATO III); 3.7 nM (SNU-16); 3.2 nM (NCI-H716).Cell Cycle Analysis Cell Line:KATO III Concentration:29.1 nM Incubation Time:72 h Result:Induced G0/G1 cycle arrest.ImmunofluorescenceCell Line:KATO IIIConcentration:100 nM Incubation Time:3 h, 6 h Result:Promoted FGFR2 was relocated from the cell membrane to intracellular vesicles after treated for 3 or 6 h. Induced receptor internalization and re-localization to the perinuclear section after 6 h treatment.Western Blot Analysis Cell Line:KATO III, NCI-H1581 Concentration: 0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM Incubation Time:6 h Result:Degraded FGFR2 with a DC50 of 11.8 nM and D max of ~80% after 6 h of treatment.Showed time-dependent effect on degradation,with a detectable reduction in FGFR2 levels after 3 h of treatment and ~90% degradation after 12 h.Degraded of FGFR2 in KATO by 77%, and in NCI-H1581 by 43% after 100 nM treatment for 6 h.
  • In Vivo
    Animal Model:SNU-16 xenografted in BALB/c-nu mice.Dosage:20 mg/kg/day Administration:oral administration (p.o.) 15 days Result:Achieved 63.1% tumor growth inhibition innocuously. Inhibited FGFR phosphorylation and total FGFR2 protein and decreased phosphorylation levels of downstream pPLCγ and ERK1/2.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PROTACs | FGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2828438-38-4
  • Formula Weight
    899.78
  • Molecular Formula
    C43H44Cl2N10O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 130 mg/mL (144.48 mM; Ultrasonic (<60°C)
  • SMILES
    O=C(NC=1C(Cl)=C(OC)C=C(OC)C1Cl)N(C=2N=CN=C(C2)NC3=CC=C(C=C3)N4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C(=O)C7=C6)C8C(=O)NC(=O)CC8)CC5)CC4)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ma L, et al. Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer. J Med Chem. 2023 Jun 8;66(11):7438-7453.?
molnova catalog
related products
  • GlyurallinB

    Glyurallin B is a flavonoid, that can be isolated from licorice (Glycyrrhiza inflata and Glycyrrhiza uralensis). Glyurallin B shows ABTS+ radical scavenging activity and the inhibitory activity on lipid peroxidation, with EC50 values of 11.9 ± 0.58 μM and 15.3 ± 1.26 μM, respectivley.

  • Trierucin

    Trierucin is a trierucic acid triglyceride from the seed oil.

  • AS057278

    AS057278 is an D-amino acid oxidase (DAAO) inhibitor.